Related Articles
Academy’s Monthly Bulletin: April 2024
Academy’s Monthly Bulletin: April 2024 A Monthly Newsletter Dedicated to Our Academy Membership Community! Academy’s Update for April 2024: Here is the summary of our…
Managing Clozapine Adverse Events
PSYCHIATRY EDUCATION FORUM ACADEMY’S MANAGING CLOZAPINE ADVERSE EVENTS UNDERSTANDING THE BASICS & BEYOND Introduction: Clozapine was FDA-approved for treatment-refractory schizophrenia in 1989 and has remained…
Academy’s Monthly Bulletin: June 2024
Academy’s Monthly Bulletin: June 2024 A Monthly Newsletter Dedicated to Our Academy Membership Community! Here is the summary of our posted Lectures, YouTube videos &…
Navigating the Complex Terrain of Drug Interactions: Hydroxychloroquine & Psychiatric Medications
In the realm of modern medicine, managing drug interactions is crucial for ensuring patient safety and efficacy of treatments. Among these interactions, those between hydroxychloroquine…
FDA Warning: Lamotrigine Risk with Cardiac Disorders
In 2021: Based on in-vitro studies, FDA added the following Cardiac rhythm and conduction abnormalities warning to lamotrigine package insert: Lamotrigine could cause serious arrhythmias…